Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Inovio reports promising data from its Covid-19 vaccine studies

INO-4800 is designed to target the major surface antigen Spike protein of SARS-CoV-2 virus. Credit: MasterTux from Pixabay.



  • Inovio vaccine
Close
Close
Close

Go Top